Ling, Walter

DSM-5 criteria for substance use disorders: recommendations and rationale

Hasin, D. S., O’Brien, C. P., Auriacombe, M., Borges, G., Bucholz, K., Budney, A., Compton, W. M., Crowley, T., Ling, W., Petry, N. M., et al. (2013) · American Journal of Psychiatry

Substance Abuse Treatment and OutcomesGambling Behavior and Treatments

Cited by 1,622

Validation of the alcohol smoking and substance involvement screening test (ASSIST)

Humeniuk, R., Ali, R., Babor, T. F., Farrell, M., Formigoni, M. L., Jittiwutikarn, J., De Lacerda, R. B., Ling, W., Marsden, J., Monteiro, M., et al. (2008) · Addiction

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 1,144

Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and Naloxone

Fudala, P. J., Bridge, T. P., Herbert, S., Williford, W. O., Chiang, C. N., Jones, K., Collins, J., Raisch, D., Casadonte, P., Goldsmith, R. J., et al. (2003) · New England Journal of Medicine

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 577

Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial

Krupitsky, E., Nunes, E. V., Ling, W., Illeperuma, A., Gastfriend, D. R., & Silverman, B. L. (2011) · The Lancet

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 555

Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial

Hser, Y., Saxon, A. J., Huang, D., Hasson, A., Thomas, C., Hillhouse, M., Jacobs, P., Teruya, C., McLaughlin, P., Wiest, K., et al. (2014) · Addiction

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 455

Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial

Ling, W., Charuvastra, C., Collins, J. F., Batki, S., Brown, L. S., Kintaudi, P., Wesson, D. R., Mcnicholas, L., Tusel, D. J., Malkerneker, U., et al. (1998) · Addiction

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 402

A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid Dependence

Ling, W. (1996) · Archives of General Psychiatry

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 366

Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent

Compton, P., Charuvastra, V. C., & Ling, W. (2001) · Drug and Alcohol Dependence

Opioid Use Disorder TreatmentPain Management and Opioid Use

Cited by 311

Long-Term Course of Opioid Addiction

Hser, Y.-I., Evans, E., Grella, C., Ling, W., & Anglin, D. (2015) · Harvard Review of Psychiatry

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 299

Hyperalgesic responses in methadone maintenance patients

Doverty, M., White, J. M., Somogyi, A. A., Bochner, F., Ali, R., & Ling, W. (2001) · Pain

Opioid Use Disorder TreatmentPain Management and Opioid Use

Cited by 297

Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Haight, B. R., Learned, S. M., Laffont, C. M., Fudala, P. J., Zhao, Y., Garofalo, A. S., Greenwald, M. K., Nadipelli, V. R., Ling, W., Heidbreder, C., et al. (2019) · The Lancet

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 285

Bupropion and naltrexone in methamphetamine use disorder

Trivedi, M. H., Walker, R., Ling, W., dela Cruz, A., Sharma, G., Carmody, T., Ghitza, U. E., Wahle, A., Kim, M., Shores-Wilson, K., et al. (2021) · New England Journal of Medicine

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 281

A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals

Rawson, R. A., McCann, M. J., Flammino, F., Shoptaw, S., Miotto, K., Reiber, C., & Ling, W. (2006) · Addiction

Substance Abuse Treatment and OutcomesBehavioral and Psychological Studies

Cited by 238

Bupropion for the treatment of methamphetamine dependence

Elkashef, A. M., Rawson, R. A., Anderson, A. L., Li, S.-H., Holmes, T., Smith, E. V., Chiang, N., Kahn, R., Vocci, F., Ling, W., et al. (2008) · Neuropsychopharmacology

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 234

A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health‐care settings in four countries

Humeniuk, R., Ali, R., Babor, T., Souza‐Formigoni, M. L. O., de Lacerda, R. B., Ling, W., McRee, B., Newcombe, D., Pal, H., Poznyak, V., et al. (2012) · Addiction

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 211

An intensive outpatient approach for cocaine abuse treatment

Rawson, R. A., Shoptaw, S. J., Obert, J. L., McCann, M. J., Hasson, A. L., Marinelli-Casey, P. J., Brethen, P. R., & Ling, W. (1995) · Journal of Substance Abuse Treatment

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 197

A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients

Margolin, A., Kosten, T. R., Avants, S. K., Wilkins, J., Ling, W., Beckson, M., Arndt, I. O., Cornish, J., Ascher, J. A., Li, S.-H., et al. (1995) · Drug and Alcohol Dependence

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 168

The effect of relapse on cognition in abstinent methamphetamine abusers

Simon, S. L., Dacey, J., Glynn, S., Rawson, R., & Ling, W. (2004) · Journal of Substance Abuse Treatment

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 142

Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers

London, E. D., Berman, S. M., Voytek, B., Simon, S. L., Mandelkern, M. A., Monterosso, J., Thompson, P. M., Brody, A. L., Geaga, J. A., Hong, M. S., et al. (2005) · Biological Psychiatry

Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and Outcomes

Cited by 136

Comparison of behavioral treatment conditions in buprenorphine maintenance

Ling, W., Hillhouse, M., Ang, A., Jenkins, J., & Fahey, J. (2013) · Addiction

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 128

Clinical efficacy of buprenorphine: comparisons to methadone and placebo

LING, W. (2003) · Drug and Alcohol Dependence

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 121

Treatment for amphetamine withdrawal

Shoptaw, S. J., Kao, U., Heinzerling, K., & Ling, W. (2009) · Cochrane Database of Systematic Reviews

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 120

Buprenorphine tapering schedule and illicit opioid use

Ling, W., Hillhouse, M., Domier, C., Doraimani, G., Hunter, J., Thomas, C., Jenkins, J., Hasson, A., Annon, J., Saxon, A., et al. (2009) · Addiction

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 112

Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence

Heinzerling, K. G., Swanson, A.-N., Kim, S., Cederblom, L., Moe, A., Ling, W., & Shoptaw, S. (2010) · Drug and Alcohol Dependence

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 105